AllCloud Launches AI Fusion, a Multi-Layer Framework Delivering 70% Faster AI Deployments

DENVER, Oct. 30, 2025 (GLOBE NEWSWIRE) — AllCloud, a leading AI-first global cloud professional and managed services company, today announced the launch of AllCloud's AI Fusion. This powerful, multi-layer framework offers a scalable architecture and repeatable accelerators designed to revolutionize how organizations accelerate and achieve successful AI initiatives. AI Fusion is the foundational blueprint that […]

Altanine Strengthens Scientific Advisory Board with Appointment of Dr. Bruce D. Forrest

Altanine Strengthens Scientific Advisory Board with Appointment of Dr. Bruce D. Forrest Industry veteran brings decades of development experience to support Altanine's mission of advancing patient-focused drug-delivery innovation GlobeNewswire October 30, 2025 LOS ANGELES, Oct. 30, 2025 (GLOBE NEWSWIRE) — Altanine, a health innovation company dedicated to improving the comfort and convenience of everyday medicines

CytomX Therapeutics to Report Third Quarter 2025 Financial Results on November 6, 2025

(NASDAQ:CTMX), SOUTH SAN FRANCISCO, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) — CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologics, today announced that it will report third quarter financial results on Thursday, November 6, 2025, after the close of U.S. markets. Following the announcement, the Company will host a

Evaxion raises $7.2 million, extending cash runway to second half of 2027

(NASDAQ:EVAX), Gross proceeds from sales of shares amounting to $4.5 million and exercise of warrants providing a further $2.7 million Total gross inflow of cash of $14.7 million since the end of the second quarter 2025 Evaxion now has cash on hand to fund its operations and R&D programs into the second half of 2027

Workhorse Reminds Shareholders to Vote Today FOR All Proposals

Workhorse Reminds Shareholders to Vote Today FOR All Proposals Visit VoteWKHS.com for Information on How to Vote GlobeNewswire October 30, 2025 CINCINNATI, Oct. 30, 2025 (GLOBE NEWSWIRE) — Workhorse Group, Inc. (Nasdaq: WKHS) (“Workhorse” or “the Company”), an American technology company focused on pioneering the transition to zero-emission commercial vehicles, today reminded shareholders to take

OrganOx Completes Acquisition by Terumo Corporation to Advance the Future of Organ Transplantation

(TSE:4543),(TSE:4543.T), OXFORD, England and MADISON, N.J., Oct. 30, 2025 (GLOBE NEWSWIRE) — OrganOx Ltd. today announced the completion of its acquisition by Terumo Corporation, following satisfaction of all customary regulatory and closing conditions. OrganOx is now a wholly owned subsidiary of Terumo, positioning the company to unlock new opportunities to evolve its technology and reach

Cloudbrink Brings Secure, Compliant, High-Performance AI to Enterprises

Cloudbrink Brings Secure, Compliant, High-Performance AI to Enterprises Cloudbrink AI Platform Gives IT and Security Teams the Control, Visibility, and Performance Needed to Ensure Safe AI Adoption in the Enterprise GlobeNewswire October 30, 2025 SUNNYVALE, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) — Cloudbrink, a leader in high-performance secure connectivity, today announced a breakthrough platform designed

Chris Benchetler Announces Mountains of the Moon

Chris Benchetler Announces Mountains of the Moon A Groundbreaking Transformative Film & Art Experience Launches Fall 2025 GlobeNewswire October 30, 2025 Mammoth Lakes, CA, Oct. 30, 2025 (GLOBE NEWSWIRE) — World-renowned artist, skier, and filmmaker Chris Benchetler unveils his most ambitious creative endeavor to date: Mountains of the Moon, a genre-defying transformative film and immersive

Rani Therapeutics to Present Preclinical Data on Oral Delivery of Semaglutide via the RaniPill(R) Capsule at ObesityWeek(R) 2025

Rani Therapeutics to Present Preclinical Data on Oral Delivery of Semaglutide via the RaniPill(R) Capsule at ObesityWeek(R) 2025 GlobeNewswire October 30, 2025 SAN JOSE, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) — Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today

Baxter International Inc. Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – BAX

Baxter International Inc. Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – BAX GlobeNewswire October 30, 2025 LOS ANGELES, Oct. 30, 2025 (GLOBE NEWSWIRE) — The DJS Law Group reminds investors of a class action lawsuit against Baxter International Inc. (“Baxter” or “the Company”) (NYSE: BAX) for violations

Scroll to Top